{"name":"Wuhan BravoVax Co., Ltd.","slug":"wuhan-bravovax-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Recombinant Zoster Vaccine","genericName":"Recombinant Zoster Vaccine","slug":"recombinant-zoster-vaccine","indication":"Other","status":"marketed"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Zoster Vaccine Recombinant, Adjuvanted","genericName":"Zoster Vaccine Recombinant, Adjuvanted","slug":"zoster-vaccine-recombinant-adjuvanted","indication":"Prevention of herpes zoster (shingles) in adults aged 50 years and older","status":"marketed"}]}],"pipeline":[{"name":"Recombinant Zoster Vaccine","genericName":"Recombinant Zoster Vaccine","slug":"recombinant-zoster-vaccine","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Zoster Vaccine Recombinant, Adjuvanted","genericName":"Zoster Vaccine Recombinant, Adjuvanted","slug":"zoster-vaccine-recombinant-adjuvanted","phase":"marketed","mechanism":"This recombinant zoster vaccine with adjuvant stimulates the immune system to generate protective antibodies and cell-mediated immunity against varicella-zoster virus (VZV) to prevent herpes zoster (shingles).","indications":["Prevention of herpes zoster (shingles) in adults aged 50 years and older","Prevention of herpes zoster in immunocompromised adults"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}